Medtronic Recall Raises Red Flag For Drug-Coated Balloons Below The Knee
This article was originally published in The Gray Sheet
Executive Summary
Drug-coated balloons have emerged as one of the next major product segments within interventional cardiology, particularly for the treatment of peripheral arterial disease. But a recent recall from Medtronic based on clinical trial data could temper enthusiasm for using the technology below the knee in patients with critical limb ischemia.